<html xmlns="http://www.w3.org/1999/xhtml"><body><table style="border: 1px solid black;"><caption /><tr><th style="border: 1px solid black;">Publication </th><th style="border: 1px solid black;">Culture model </th><th style="border: 1px solid black;">Cases </th><th style="border: 1px solid black;">Cells </th><th style="border: 1px solid black;">Summary of fndings </th></tr><tr><td style="border: 1px solid black;">Chen</td><td style="border: 1px solid black;">Fibroblasts → iPSC</td><td style="border: 1px solid black;">Three cases BPD type 1</td><td style="border: 1px solid black;">Forebrain phenotype</td><td style="border: 1px solid black;">2547 genes expression diff. between BPD/healthy</td></tr><tr><td style="border: 1px solid black;">et al. (2014)</td><td style="border: 1px solid black;">Retroviral vector (OCT4,</td><td style="border: 1px solid black;">2 Li+ responders, one</td><td style="border: 1px solid black;">VGlut+</td><td style="border: 1px solid black;">subjects’iPSC</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">SOX2, KLF4, c-MYC)</td><td style="border: 1px solid black;">non-responder</td><td style="border: 1px solid black;">pyramidal-shaped</td><td style="border: 1px solid black;">186 genes expression ↑BPD (&gt; 1.5 fold) in iPSC</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">iPSC → NPC → iNeurons</td><td style="border: 1px solid black;">three age-matched</td><td style="border: 1px solid black;">neurons,</td><td style="border: 1px solid black;">46 genes expression ↓BPD (&gt; 1.5 fold) in iPSC</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">Embryoid body medium</td><td style="border: 1px solid black;">healthy controls</td><td style="border: 1px solid black;">GABA+ interneurons,</td><td style="border: 1px solid black;">1312 genes expression diff. between BPD/healthy</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">and neuron induction</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">scattered serotonergic</td><td style="border: 1px solid black;">subjects’iN</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">medium</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">and dopaminergic</td><td style="border: 1px solid black;">140 genes expression ↑BPD (&gt; 1.5 fold) in iN</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">neurons</td><td style="border: 1px solid black;">46 genes expression ↓BPD (&gt; 1.5 fold) in iN</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">BPD-derived neurons show higher expression of</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">DICER1, NKX2-1 and PAX2 but lower expression</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">of EMX2 and HOXA1,6,7</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">Li+ pre-treatment reduces Ca++ transient and wave</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">amplitude in BPD-derived iNs compared to healthy</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">subject derived iNs</td></tr><tr><td style="border: 1px solid black;">Wang</td><td style="border: 1px solid black;">Fibroblasts direct conversion</td><td style="border: 1px solid black;">Twelve cases BPD type 1</td><td style="border: 1px solid black;">Heterogeneous cell</td><td style="border: 1px solid black;">Cells derived from Li+ responders show</td></tr><tr><td style="border: 1px solid black;">et al. (2014)</td><td style="border: 1px solid black;">Lentiviral vector</td><td style="border: 1px solid black;">and history of</td><td style="border: 1px solid black;">population, no</td><td style="border: 1px solid black;">greater adhesion than cells from</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">(miRNA-9/9*-123,</td><td style="border: 1px solid black;">Li+ treatment</td><td style="border: 1px solid black;">capability to produce</td><td style="border: 1px solid black;">Li+ non-responders as measured by</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">NEUROD2, ASCL1,</td><td style="border: 1px solid black;">Six responders</td><td style="border: 1px solid black;">action potentials</td><td style="border: 1px solid black;">ΔPWV (Peak Wave Length) in a BIND scanner</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">MYT1L)</td><td style="border: 1px solid black;">Six non-responders</td><td style="border: 1px solid black;">without further</td><td style="border: 1px solid black;"></td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">Six healthy subjects</td><td style="border: 1px solid black;">differentiation and</td><td style="border: 1px solid black;"></td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">expressing neuronal</td><td style="border: 1px solid black;"></td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">as well as stem-cell</td><td style="border: 1px solid black;"></td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">markers</td><td style="border: 1px solid black;"></td></tr><tr><td style="border: 1px solid black;">Madison</td><td style="border: 1px solid black;">Fibroblasts → iPSC</td><td style="border: 1px solid black;">Two offspring</td><td style="border: 1px solid black;">Mixed population</td><td style="border: 1px solid black;">Neurons could be generated from all healthy subjects’</td></tr><tr><td style="border: 1px solid black;">et al. (2015)</td><td style="border: 1px solid black;">Retroviral vector (vector</td><td style="border: 1px solid black;">(BPD Type 1)</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">iPSC but only 2/6 BPD iPSC lines. NPCs could be</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">(OCT4, SOX2, KLF4,</td><td style="border: 1px solid black;">GM05224 GM05225</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">generated from all lines, but not propagated beyond</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">c-MYC))</td><td style="border: 1px solid black;">Coriell Cell Repository</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">4–5 passages. No expression of PAX6</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">iPSC → NPC → iNeurons</td><td style="border: 1px solid black;">Two parents (healthy)</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">Bromodeoxyuridine staining (proliferation) ↓in BPD</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">NPC medium, neurobasal</td><td style="border: 1px solid black;">GM08330 GM08329</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">NPCs</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">medium</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">BPD neurons show ↓↓viability after 2 weeks of</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">differentiation; hardly any neurons were found</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">after 6 weeks</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">In iPSCs and fbroblasts, hardly any difference</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">between BPD and healthy subjects</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">In NPCs, 18 genes &gt; 1.5 fold expression</td></tr><tr><td style="border: 1px solid black;">Mertens</td><td style="border: 1px solid black;">Fibroblasts → iPSC → NPCs</td><td style="border: 1px solid black;">Six cases, BPD Type 1</td><td style="border: 1px solid black;">Hippocampal dentate</td><td style="border: 1px solid black;">Expression of mitochondrial genes in BPD ↑</td></tr><tr><td style="border: 1px solid black;">et al. (2015)</td><td style="border: 1px solid black;">Cyto-Tune Sendai</td><td style="border: 1px solid black;">Recruited during a</td><td style="border: 1px solid black;">gyrus (DG)</td><td style="border: 1px solid black;">Overall smaller mitochondria</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">reprogramming kit</td><td style="border: 1px solid black;">prospective trial for</td><td style="border: 1px solid black;">granule cell-like</td><td style="border: 1px solid black;">mitochondrial function in JC-1 Assay in BPD ↑</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">(commercial) → NPCs</td><td style="border: 1px solid black;">Li+ monotherapy</td><td style="border: 1px solid black;">neurons</td><td style="border: 1px solid black;">Increased excitability in BPD iPSC neurons. Altered</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">DKK1 Cyclopamine,</td><td style="border: 1px solid black;">(three Li+ responders,</td><td style="border: 1px solid black;">&gt; 80% VGLUT1+</td><td style="border: 1px solid black;">action potential frequency, Ca++ signalling PKA/C</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">Noggin → iNeurons</td><td style="border: 1px solid black;">three Li+</td><td style="border: 1px solid black;">2–7% GABAergic</td><td style="border: 1px solid black;">signalling.</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">WNT3A, BDNF</td><td style="border: 1px solid black;">non-responders)</td><td style="border: 1px solid black;">(characterized by</td><td style="border: 1px solid black;">In Li+ responders, action potential frequency was</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">Four healthy subjects</td><td style="border: 1px solid black;">GABA release)</td><td style="border: 1px solid black;">attenuated by Li+ but not in non-responders. Li+ alters</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">gene expression differently in responders and</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">non-responders and seems to rescue disease relevant</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">genes. Li+ increases mitochondria size.</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">Electrophysiological alterations in non-responders</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">were attenuated by lamotrigine</td></tr><tr><td style="border: 1px solid black;">Bavamian</td><td style="border: 1px solid black;">iPSC → NPCs</td><td style="border: 1px solid black;">iPSC: I case BPD type 1</td><td style="border: 1px solid black;">Not stated</td><td style="border: 1px solid black;">miRNA-34a ↑in BPD patient cerebellum slices</td></tr><tr><td style="border: 1px solid black;">et al. (2015)</td><td style="border: 1px solid black;">Retroviral vector (vector</td><td style="border: 1px solid black;">Coriell Cell Repository</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">(without Li+ treatment) as well as in both cell models</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">(OCT4, SOX2, KLF4,</td><td style="border: 1px solid black;">GM05224 and one</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">25 putative miR-34a targets were identifed. ANK3,</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">c-MYC))</td><td style="border: 1px solid black;">healthy subject</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">CACNA1C, CACNB3, ODZ4, DDN, and KLC2</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">NPCs→iNeurons</td><td style="border: 1px solid black;">GM08330</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">overlap with BPD GWAS loci.</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">In NPC and neuronal</td><td style="border: 1px solid black;">iN fve cases</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">miRNA-34a targets were downregulated with increased</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">differentiation media</td><td style="border: 1px solid black;">BPD type 1</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">expression of the miRNA in NPCs and early neurons</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">Fibroblasts → iNeuron:</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">derived from a BPD patient.</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">direct conversion from</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">ANK3 and CACNB3 were up regulated as miRNA-34a</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">fbroblasts</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">was blocked in healthy subject and BPD-derived iPSC</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">Lentiviral vector</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">neurons.</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">(miRNA-9/9*-123,</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">miRNA-34a impairs pre- and post-synaptic</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">NEUROD2, ASCL1,</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">development; dentritic branching ↓</td></tr><tr><td style="border: 1px solid black;"></td><td style="border: 1px solid black;">MYT1L)</td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td><td style="border: 1px solid black;"></td></tr></table></body></html>